Suven Life gets patents for neuro-degenerative drug savita thakur thakur13 July 2016 2:03 PM ISTNew Delhi : Drug firm Suven Life Sciences has been granted a patent each by India and South Africa for a drug used in treatment of neuro-degenerative...
Opto Circuits to launch new catheter for dialysis patients savita thakur thakur13 July 2016 2:02 PM ISTNew Delhi : Medical devices firm Opto Circuits Germany-based subsidiary Eurocor will launch coated shunt balloon catheter used for patients undergoing...
Confusion prevails over banned FDC drugs Geeta Sharma Sharma12 July 2016 12:10 PM ISTNew Delhi: Serious confusion prevails in the absence of clarity on the High Court interpretation of implementation of ban on some ‘Fixed Dose...
Novartis copy of Amgen arthritis drug highly similar: FDA staff savita thakur thakur12 July 2016 11:55 AM ISTNovartis AG's cheaper version of Amgen Inc's blockbuster arthritis drug Enbrel is highly similar in potency and safety to the original, according to a...
Zydus Cadila gets USFDA nod for diabetes treatment drug savita thakur thakur12 July 2016 11:54 AM ISTNew Delhi : Drug firm Zydus Cadila has received final approval from the US health regulator to market Nateglinide tablets, used for treatment of...
Ajanta Pharma's 300 cr formulation facility boosts markets Geeta Sharma Sharma11 July 2016 2:39 PM ISTNew Delhi: A 1,700 crore pharmaceutical business group Ajanta Pharma from Mumbai is setting up a Rs. 300 crore new formulations facility at Guwahati...
E-commerce helping easy availability of pharma drugs and abuse savita thakur thakur11 July 2016 2:29 PM ISTNew Delhi : Growing e-commerce in India is facilitating significant increase in online pharmacies, leading to easy availability of pharmaceutical...
Novartis announces FDA approval of Xolair® (omalizumab) for pediatric allergic asthma savita thakur thakur11 July 2016 2:27 PM ISTNovartis announced that the US Food and Drug Administration (FDA) has approved an expanded age range for Xolair® (omalizumab) to include children six...
USFDA finds minor violations at Lupin's Dabhasa plant savita thakur thakur10 July 2016 4:10 PM ISTNew Delhi : Drug firm Lupin said US health regulator has voiced minor concerns after completing the inspection of its Dabhasa facility in...
Cadila Healthcare gets EIR from USFDA for Moraiya facility savita thakur thakur10 July 2016 4:06 PM ISTNew Delhi : Drug firm Cadila Healthcare has received Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility...
Cipla to invest Rs 590 crore for a biosimilars plant in South Africa savita thakur thakur10 July 2016 4:06 PM ISTNew Delhi : Drug firm Cipla will invest around Rand 1.3 billion (over Rs 590 crore) to launch a manufacturing facility in South Africa for the...
Amgen drug appears highly similar to Humira: FDA staff savita thakur thakur10 July 2016 4:05 PM ISTAmgen Inc's version of AbbVie Inc's Humira arthritis drug, the world's top-selling medicine, appears similar in potency and safety to the original...
